Argo Biopharma logo

Argo Biopharma

Committed to developing a new generation of siRNA drugs to provide better treatments for global patients.

8 employees · est. 2021 · Shanghai, China

VS
Enterome logo

Enterome

Delivering the promise of immunotherapy

49 employees · est. 2011 · Paris, France

Enterome is the older company (2021 vs 2011); Enterome is the larger of the two.

Side-by-Side Comparison

Argo Biopharma Enterome
Founded
2021 2011 older
Headquarters
Shanghai, China Paris, France
Employees
8 49 larger
Industry
Biotechnology Biopharma, Biotechnology, Health Care
Funding Stage
Series A Series Unknown
Total Funding
$700.00M $175.80M
Funding Rounds
2 9
Services
Not tracked yet Development of off-the-shelf cancer immunotherapy treatments
Target Customers
Not tracked yet Patients with B cell malignancies, Glioblastoma, adrenal tumors, and colorectal cancer
Taxonomy
Not tracked yet Immunotherapy, Biopharmaceuticals, Drug Discovery, OncoMimics, Cancer Treatment, Immunomodulatory Drugs, Phase 2 Clinical Trials, Tumor Associated Antigens, CD8 T Cell Response, Glioblastoma, Adrenal Malignancies, Colorectal Cancer, Clinical-stage Biotech, Immunotherapies, Metagenomics
Website
argobiopharma.com enterome.com
Argo Biopharma logo

About Argo Biopharma

Argo Biopharma is a clinical stage biotech company that committed to developing a new generation of siRNA drugs to provide better treatments for global patients. In the past three years, Argo biopharma has built a rich and differentiated pipeline of siRNA drug candidates for a wide range of indicati...

Enterome logo

About Enterome

Enterome is a clinical-stage biopharmaceutical company founded in 2011 and headquartered in France. It focuses on delivering the promise of immunotherapy through the development of breakthrough immunomodulatory drugs for the treatment of cancer and immune diseases. The company's unique approach to d...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Argo Biopharma and Enterome — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Argo Biopharma and Enterome — by email.

Frequently Asked Questions

Argo Biopharma — Committed to developing a new generation of siRNA drugs to provide better treatments for global patients.. Enterome — Delivering the promise of immunotherapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Argo Biopharma has raised $700.00M while Enterome has raised $175.80M.
Argo Biopharma and Enterome operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Argo Biopharma with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy